Barry Antonacci - Concepedia

Author

Barry Antonacci

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

B Antonacci, B. Antonacci, Barry Antonacci

Publications

255

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Barry Antonacci is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and antifungal agents.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	125
2	Immunology	3	3	50
3	Health Sciences	1	1	13
4	Natural Sciences	1	1	75
5	Biochemistry	1	1	75

Barry Antonacci

Publications

242

Citations

H-Index

Page 1

	Year	Citations
In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against <i>Aspergillus</i> and <i>Candida</i> Anthony Cacciapuoti, David Loebenberg, Erik Corcoran, Antimicrobial Agents and Chemotherapy	2000	99
Discovery of a Novel Class of Orally Active Antifungal β-1,3- <scp>d</scp> -Glucan Synthase Inhibitors Scott S. Walker, Yiming Xu, Ilias Triantafyllou, Antimicrobial Agents and Chemotherapy Medicinal ChemistryAntifungal AgentBiochemistrySpontaneous MutantsAntifungal Agents	2011	75
In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304 David Loebenberg, Anthony Cacciapuoti, Raulo Parmegiani, Antimicrobial Agents and Chemotherapy Sch 42426Medicinal ChemistryAntifungal AgentActive EnantiomerVivo Activities	1992	22
Relationship Among Physicochemical Properties, Skin Permeability, and Topical Activity of the Racemic Compound and Pure Enantiomers of a New Antifungal Lorraine Wearley, Barry Antonacci, Anthony Cacciapuoti, Pharmaceutical Research	1993	18
Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B Raulo Parmegiani, David Loebenberg, Barry Antonacci, Antimicrobial Agents and Chemotherapy Medicinal ChemistryPharmaceutical ScienceAntifungal AgentDrug ResistanceVivo Evaluation	1987	15
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice Anthony Cacciapuoti, David Loebenberg, Raulo Parmegiani, Antimicrobial Agents and Chemotherapy Antifungal AgentHealth SciencesSystemic InfectionsSurvival RatesAntifungal Agents	1992	13

Page 1